Novasep

Novasep, established in 1998, is a significant player in the Pharmaceuticals and Healthcare sectors, operating as an international provider of specialized services for the Life Science industry. The company focuses on advanced molecule production and purification, offering a range of solutions from R&D to industrial-scale manufacturing. Its expertise spans complex chemical synthesis, process development, and the provision of purification technologies. With a workforce of 1,000 - 5,000 employees, Novasep manages operations across 9 locations globally. The company's service portfolio includes contract manufacturing, process development services, and turnkey process solutions, catering to biopharmaceutical, pharmaceutical, and food industries. Key product areas involve chromatography, custom manufacturing services, and specialized chemical production. Meet Novasep's team to understand the expertise driving these operations. Generating substantial revenue of $323.2M, Novasep demonstrates robust financial performance. The company has secured funding, including an 'Other Financing Round' of $10.0M in May 2018, supporting its growth and development initiatives. Novasep's strategic focus on cost-effective, sustainable industrial manufacturing and high-performance purification technologies positions it within a competitive market. Explore financial highlights for a deeper dive into its fiscal standing and investment history.